At the end of Q3 2024, 32 institutions reported holding Tonix Pharmaceuticals HLDG C in their 13F filings, up 10 from Q2 2024. 18 opened new positions and 9 sold out. The largest holders were Millennium Management ($54K), UBS Group AG ($36K) and Virtu Financial LLC ($20K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
Company
Tonix Pharmaceuticals HLDG C
CUSIP
890260847
Latest filing quarter
Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
Institutions
Total Value
New Positions
18
$95K
Exits
9
$184K
All 13F filers, Q2 2024 → Q3 2024: 1,030,255 shares bought and 265,198 shares sold, net +765,057 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
"% of holder's portfolio" is TONIX PHARMACEUTICALS HLDG C's weight in each manager's 13F, not the share of Tonix Pharmaceuticals HLDG C the manager owns.